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Background: Frailty is superior to chronological age as a predictor of
outcome. The Edmonton Frail Scale (EFS) is a simple valid measure of
frailty, covering multiple important domains, with scores ranging from
0 (not frail) to 17 (very frail). The purpose of this pilot study was to
assess the EFS in a group of elderly patients with acute coronary
syndrome (ACS).
Methods: The EFS was administered to 183 consecutive patients with
ACS aged 65 years admitted to a single centre in Edmonton, Alberta,
Canada.
Results: Scores ranged from 0-13. Patients with higher EFS scores
were older, with more comorbidities, longer lengths of stay (EFS 0-3:
mean, 7.0 days; EFS 4-6: mean, 9.7 days; and EFS  7: mean, 12.7
days; P ¼ 0.03), and decreased procedure use. Crude mortality rates
at 1 year were 1.6% for EFS 0-3, 7.7% for EFS 4-6, and 12.7% for EFS
 7 (P ¼ 0.05). After adjusting for baseline risk differences using
a “burden of illness” score, the hazard ratio for mortality for EFS  7
compared with EFS 0-3 was 3.49 (95% conﬁdence interval [CI],
1.08-7.61; P ¼ 0.002).
Conclusions: The EFS is associated with increased comorbidity, longer
lengths of stay, and decreased procedure use. After adjustment
for burden of illness, the highest frailty category is independentlyReceived for publication July 10, 2013. Accepted August 27, 2013.
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Introduction : La fragilite est superieure à l’âge chronologique en
matière de predicteur des resultats cliniques. L’Edmonton Frail Scale
(EFS) est une mesure ﬁable et simple de la fragilite, couvrant plusieurs
domaines importants et utilisant des scores allant de 0 (non fragile) à
17 (très fragile). Le but de cette etude pilote etait d’evaluer l’EFS chez
un groupe de patients âges ayant un syndrome coronarien aigu (SCA).
Methodes : Cent quatre-vingt-trois (183) patients consecutifs âges
 65 ans ayant un SCA et etant admis à un seul centre d’Edmonton,
en Alberta, au Canada, ont rempli l’EFS.
Resultats : Les scores allaient de 0 à 13. Les patients ayant des
scores plus eleves à l’EFS etaient plus âges, avaient plus de
comorbidites, des sejours plus longs (EFS, 0 à 3 : moyenne, 7,0 jours;
EFS, 4 à 6 : moyenne, 9,7 jours; EFS  7 : moyenne, 12,7 jours; P ¼
0,03) et une diminution de l’utilisation d’interventions. Les taux de
mortalite bruts à 1 an etaient de 1,6 % pour un score de 0 à 3 à l’EFS,
de 7,7 % pour un score de 4 à 6 à l’EFS et de 12,7 % pour un score  7
à l’EFS (P ¼ 0,05). Après l’ajustement des differences de risque initial
au moyen du score du « fardeau de la maladie », le rapport de risque
de mortalite quant à un score  7 à l’EFS comparativement à un score
de 0 à 3 à l’EFS etait de 3,49 (intervalle de conﬁance [IC] à 95 %,
1,08-7,61; P ¼ 0,002).Cardiovascular disease is a leading cause of morbidity and
mortality in older individuals, and managing elderly patients
can be challenging. Chronological age is an independent risk
factor for adverse outcomes in many conditions and is oftenincluded in risk indices.1-3 However, the assessment of frailty
in elderly patients is emerging as a superior predictor when
compared with chronological age. Frailty can be conceptu-
alized as a phenotype of weight loss, fatigue, and weakness or
a multidimensional state of vulnerability arising from
a complex interplay of biological, cognitive, and social
factors.4-8 Compared with age-matched cohorts, frail indi-
viduals are at higher risk of functional disability, institu-
tionalization, and death. Unfortunately, methods used to
assess frailty can be impractical in busy clinical settings,
because the phenotype model is narrow in scope and requires
special equipment,4 and most multidimensional modelsd by Elsevier Inc. All rights reserved.
associated with mortality in elderly patients with ACS. Further work is
needed to determine whether the use of a validated frailty instrument
would better delineate medical decision making in this important,
often disadvantaged population.
Conclusions : L’EFS est associee à une augmentation de la
comorbidite, à des sejours plus longs et à une diminution de l’utilisa-
tion d’interventions. Après l’ajustement du fardeau de la maladie, la
categorie la plus elevee de fragilite est independamment associee à la
mortalite chez les patients âges ayant un SCA. D’autres recherches
sont necessaires pour determiner si l’utilisation d’un instrument de
fragilite ﬁable pourrait mieux orienter la prise de decision medicale
chez cette importante population, souvent defavorisee.
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Frailty and Outcome in ACSrequire comprehensive geriatric assessment or special
training, or both.5-8
A brief user-friendly screening interview for frailty in
seniors (the Edmonton Frail Scale [EFS]) was developed and
validated for use by nongeriatricians.9,10 The purpose of this
pilot cohort study was to expand the validation of the EFS to
a group of elderly patients with acute coronary syndrome
(ACS) and to determine the association of frailty, as
measured by the EFS, with mortality.Methods
The EFS
Using a series of simple questions or tasks, the EFS
(Table 1) assesses cognitive impairment, dependence for
activities of daily living, burden of illness, self-perceived
health, depression, weight loss, medication issues, inconti-
nence, social support, and mobility (using the timed “get up
and go” test). Scores range from 0 (not frail) to a maximum of
17 (very frail). The EFS does not depend on formal medical
training to administer, requires less than 5 minutes of theTable 1. Domains of the Edmonton Frail Scale
Frailty domain Item
Cognition Clock diagram: Place the numbers in
the correct positions then place the
hands to indicate a time of “10 after
11”
No er
General health status Hospital admissions in past year 0
General health description Excell
Functional independence Requires assistance with activities such
as meal preparation, shopping,
transportation, dialing telephone,
housekeeping, laundry, managing
money, taking medications
0-1
Social support Availability of individuals who are
willing and able to support patient
needs
Alway
Medication use Five or more different prescription
medications on a regular basis
No
Forgetfulness about taking prescription
medications
No
Nutrition Weight loss No
Mood Reported feelings of sadness or
depression
No
Continence Unexpected urinary incontinence No
Functional performance
(timed get up and go test)
Patient begins by sitting in a chair with
back and arms resting, then stands
up and walks approximately 3 m,
and returns to the chair and sits
down
0-10 s
Totals Final score is sum of column totalspatient’s time, and is a valid measure of frailty compared with
the clinical impression of geriatric specialists after their more
comprehensive assessment.9,10
We approached all patients aged 65 years or older with
a diagnosis of ACS who were admitted over a period of
6 months to the cardiology inpatient unit at the University of
Alberta Hospital, which is an academic tertiary care centre
in Edmonton, Alberta, Canada. Exclusion criteria were
mechanical ventilation, hemodynamic instability requiring
urgent/emergent treatment, and inability to give consent for
reasons of language barrier, delirium, known pre-existing
cognitive impairment, or signiﬁcant visual or hearing
impairment. Patients were approached as soon as possible after
admission, and the EFS was administered before any invasive
testing was completed. For those patients who were prescribed
strict bed rest, mobility assessment using the timed get up and
go test was performed as soon as this clinical restriction was
lifted. Health care providers were blinded to the results of the
EFS assessment. The study protocol was approved by the
Institutional Review board of the University of Alberta.
Because this was a pilot study with a relatively small
cohort, a decision was made to categorize the EFS into0 points 1 point 2 points
rors Minor spacing errors Other errors
1-2  2
ent, very good, good Fair Poor
2-4 5-8
s Sometimes Never
Yes
Yes
Yes
Yes
Yes
11-20 s > 20 s, patient unwilling
or requires assistance
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in patients undergoing noncardiac surgery.11 The following
categories were established: EFS 0-3, EFS 4-6, and EFS 7 to
ensure relatively equal numbers of patients in each of the 3
groups.
Real-time chart review conducted during hospital admis-
sion conﬁrmed the diagnosis of ACS. Baseline patient data
were then collected and entered into the admissions module
of the Alberta Provincial Project for Outcomes Assessment
in Coronary Heart Disease (APPROACH registry).
APPROACH is a clinical data collection initiative capturing
all patients undergoing cardiac catheterization in Alberta,
Canada since 1995,12 and expanded to collect data related to
cardiac admissions in 2004. APPROACH contains detailed
demographic and clinical information and tracks therapeutic
interventions and revascularization procedures. Data
collected in the admissions module correspond to the baseline
predictor variables collected in APPROACH: age, sex, ejec-
tion fraction, the presence or absence of previous myocardial
infarction, congestive heart failure, diabetes, cerebrovascular
disease, peripheral vascular disease, chronic pulmonary
disease, elevated creatinine levels, need for dialysis, hyper-
lipidemia, hypertension, liver or gastrointestinal disease, and
malignancy. Previous therapeutic interventions such
as medications, thrombolytic therapy, revascularization
including coronary artery bypass grafting (CABG) or percu-
taneous coronary intervention (PCI) are also tracked. Patients
undergoing cardiac catheterization have coronary anatomy
and procedural data (including revascularization procedures)
collected. Follow-up mortality is ascertained through quar-
terly linkage to data from the Alberta Bureau of Vital
Statistics.Table 2. Patient characteristics
Characteristic
EFS 0-3 EFS 4-6 EFS  7
P valuen ¼ 63 n ¼ 65 n ¼ 55
Mean age (y) 73.9 75.3 77.2 0.031
Sex (% female) 22.2 38.5 38.2 0.088
Hypertension (%) 61.3 86.2 96.4 < 0.001
Dyslipidemia (%) 84.1 92.3 85.5 0.328
Diabetes (%) 14.3 27.7 45.5 0.001
Smoking (%) 7.9 12.3 16.4 0.571
Renal disease (%) 6.7 14.1 29.6 0.003
Congestive heart failure (%) 4.8 9.2 35.2 < 0.001
Peripheral vascular disease (%) 4.8 7.7 9.1 0.642
Cerebrovascular disease (%) 7.9 10.8 25.5 0.015
Previous MI (%) 22.2 40.0 43.6 0.030
Previous PCI (%) 17.5 29.2 34.5 0.096
Previous CABG (%) 8.1 18.5 18.5 0.203
STEMI (%) 23.8 18.5 14.5 0.436
Malignancy (%) 8.1 9.2 11.1 0.854
Pulmonary disease (%) 11.3 16.9 29.6 0.113
Liver disease (%) 0.0 0.0 1.9 0.448
GI disease (%) 10.0 9.2 14.8 0.734
Treatment received
Cardiac catheterization (%) 88.9 86.2 58.2 < 0.001
PCI (%) 36.5 26.2 16.4 0.047
CABG (%) 12.7 18.5 9.1 0.364
Length of stay (mean d) 7.0 9.7 12.7 0.026
CABG, coronary artery bypass grafting; CAD, coronary artery disease;
EFS, Edmonton Frail Scale; GI, gastrointestinal; LV, left ventricle; MI,
myocardial infarction; PCI, percutaneous intervention; STEMI, ST-segment
elevation MI.Statistical analysis
Patient characteristics among the 3 frailty groups were
compared using t tests and c2 tests. Kaplan-Meier plots and
log-rank tests were used to determine and compare crude
mortality rates. Using linear regression and age as the outcome
variable, a model was developed that included all of the
clinical variables contained in Table 2. The predicted “age” of
the modelling process was saved and used as a surrogate for the
“burden of illness” score in subsequent regression analyses. A
Cox regression analysis was then conducted using the burden
of illness variable and the frailty categories to assess the
association of these variables with survival. To ﬁt the small
sample size, bootstrapping was used to derive robust estimates
of the standard errors and conﬁdence intervals for the
regression coefﬁcient (hazard ratios).
Secondary outcomes of interest included length of hospi-
talization (also assessed with the EFS as a continuous variable),
use of cardiac catheterization, and revascularization procedures
(CABG and PCI).
Statistical analyses were performed using IBM SPSS
Statistics, version 20 (SPSS, Chicago, IL).
Results
Over a 6-month period, the EFS was administered to 183
consecutive patients aged 65 years who were admitted with
a conﬁrmed diagnosis of ACS. The EFS on average required
< 5 minutes to administer. Scores ranged from 0-13
(maximum 17 points), with higher scores indicating higher
levels of frailty. Categorization of the patient cohort into
tertiles resulted in 63 patients with an EFS score of 0-3, 65
patients with an EFS score of 4-6, and 55 patients with an EFS
score of  7.
Table 2 shows the baseline characteristics of these patients.
Patients with higher EFS scores were older and more likely to
have a history of hypertension, previous myocardial infarction,
congestive heart failure, and chronic kidney disease. EFS scores
 7were associated with a substantial proportion of congestive
heart failure in > 33% of patients and cerebrovascular disease
in 25%. Higher EFS scores were also associated with longer
mean hospital lengths of stay (7.0 days for EFS 0-3, 9.7 days for
EFS 4-6, and 12.7 days for EFS  7; P ¼ 0.03).
Table 2 also illustrates that patients in the highest EFS
category were less likely to undergo cardiac catheterization
(58% of patients with EFS  7 compared with > 86% of
patients in the other EFS categories with lower scores).
Patients in this highest EFS category group were also less
likely to receive subsequent revascularization procedures,
particularly PCI, although this ﬁnding was not statistically
signiﬁcant for CABG.
Figure 1 presents the Kaplan-Meier curves for survival to
1 year of follow-up after hospitalization for ACS. Crude
mortality rates at 1 year were 1.6% for EFS 0-3, 7.7% for EFS
4-6, and 12.7% for EFS  7 (P ¼ 0.05).
Using all the clinical characteristics found in Table 2,
a linear regression model was run, with age at assessment as
the outcome variable. The predicted scores were used as
a proxy variable, which we labelled “burden of illness.” Cox
regression analysis, including the burden of illness variable
and the EFS categories, was then performed. Using the EFS
3 category as a referent, the adjusted hazard ratio for EFS 4-6
Figure 1. Kaplan-Meier survival curves for the 3 different frailty groups followed up to 3 years after admission for acute coronary syndrome (ACS).
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Frailty and Outcome in ACSwas 1.31 (95% CI, 0.55-3.13) and for EFS  7, it was 3.49
(95% CI, 1.08-7.61), indicating that after adjustment for
burden of illness, the highest frailty category remained
independently associated with mortality in this ACS cohort.Discussion
In this pilot study, we demonstrated that a simple user-
friendly instrument to assess frailty at the bedside is associ-
ated with increasing comorbidity, hospital lengths of stay,
lower use of invasive procedures, and increased mortality in
a known high-risk populationdelderly patients with ACS.
The EFS has been successfully used in other important clin-
ical situations, including noncardiac surgery, in which higher
EFS scores were associated with an increase in postoperative
complications, increased length of stay, and an inability to be
discharged home.11 Most recently, frailty as measured by the
EFS was found to be associated with lower use of warfarin for
stroke prevention in atrial ﬁbrillation and an increased rate of
embolic stroke.13
A recent systematic review demonstrated that > 50% of
elderly patients with cardiovascular disease are frail, and frailty
is known to be associated with an increase in mortality incommunity-dwelling patients with cardiovascular disease.14
The complexity of some methods of frailty assessment does
make more simple tools attractive from the perspective of ease
of use and time required to administer tests. Although simple
tools may lose some nuances, they can still be predictive, as
was demonstrated when the simple Study of Osteoporotic
Fracture Index, with 3 domains, was found to predict the risk
of falls, disability, fractures, and mortality as well as the more
complex Cardiovascular Health Study Index.15,16 Gait speed
(1 simpler measure of frailty) in hospitalized older patients
with known coronary artery disease was found to be the
strongest predictor of 6-month mortality.17 Similarly, the 6-
minute walk test administered in older adults with heart
failure was found to be independently predictive of
mortality.18 However, although easy to administer, gait speed
and the 6-minute walk test do not assess the other critical
domains associated with frailty. Freiheit et al. recently
developed a frailty index in elderly patients undergoing
cardiac catheterization, which includes physical, cognitive.
and psychosocial criteria.19 However, this model has not yet
been validated in other settings. The EFS therefore has
advantages because it has been validated in multiple clinical
situations and assesses multiple domains.
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characteristics according to degree of frailty, with an increase
in clinically signiﬁcant comorbidities, which would by their
very nature correlate with increased cardiovascular risk.
Correspondingly, these patients were less likely to receive
cardiac catheterization and revascularization procedures and
had signiﬁcantly higher mortality rates. Clinical trials and
large observational studies suggest that invasive investigation
and revascularization in appropriately selected elderly patients
with coronary artery disease leads to decreased mortality and
major adverse cardiac events and improved quality of life.20-23
However, patient selection is critical, and Yan et al. previously
demonstrated that physicians may not be incorporating
readily available adverse prognosticators into patient risk
assessment.24 Furthermore, these studies did not include
objective measures of frailty. The risks of increasing morbidity
and mortality with revascularization procedures have collec-
tively raised clinical thresholds for considering these proce-
dures in the elderly. Indeed, a recent study also demonstrated
that patients who are objectively identiﬁed as being frail but
who undergo major cardiac surgical procedures have signiﬁ-
cantly increased risk for in-hospital and midterm mortality. In
addition, these frail surgical patients are more likely to expe-
rience postoperative complications and require discharge to
institutional care.25 In very frail patients, therefore, the use of
fewer invasive procedures may be completely appropriate,
because the risks of procedures begin to outweigh the beneﬁts.
This emphasizes the importance of individually tailored
informed consent and highlights the potential advantage of
incorporating frailty into risk assessments.
Another consideration is the potential of a simple frailty
assessment to identify issues in individual patients that are
possibly modiﬁable. For example, one could envision inter-
ventions through social work and home care to improve
functional independence, social support, medication
compliance, and nutrition. Such interventions have previ-
ously been demonstrated to be effective in elderly patients
with heart failure.26 Cardiac rehabilitation programs are
associated with improved outcomes, even in older individ-
uals.27,28 Cardiac rehabilitation is also associated with
improvements in depressive symptoms in older patients.29
Finally, recent studies have shown that resistance training
can improve cognitive performance in patients with subjective
memory impairment, potentially at a cost savings.30,31
Although older patients are less likely to participate in these
programs,32 investigators have also found that simple inter-
ventions such as early appointments after discharge improve
attendance.33 Further work is therefore required to determine
whether it is possible to “defrail” a frail patient and to identify
the relationship potential frailty interventions may have to
outcomes.
There are limitations to this study. It is a single-centre pilot
study involving a relatively small number of patients, with
limited power to evaluate other important major adverse
outcomes; therefore, generalizability may be a concern.
However, our ﬁndings are in keeping with other studies of
frailty in general, and furthermore all CIs and signiﬁcance
tests were computed based on the standard errors of the
bootstrap samples. The small numbers also prevent assess-
ment of the relative contributions of the individual domains
measured in the EFS to outcome. Finally, the relationshipbetween frailty and quality of life is an important consider-
ation that requires further research.Conclusions
In conclusion, we have expanded the use of a simple frailty
assessment tool administered by nongeriatricians to a group of
elderly patients with ACS. Higher EFS scores are associated
with increased comorbidity, longer lengths of stay, and
decreased procedure use. Furthermore, after adjusting for
baseline risk factor differences using a burden of illness vari-
able, high EFS scores are associated with increased mortality.
This simple tool therefore has the potential to serve as
a practical and clinically meaningful measure of frailty in
a variety of settings. Further work is needed to determine
whether the use of a validated frailty instrument to better
delineate some of the “unmeasured factors” involved in
medical decision making in elderly patients with cardiovas-
cular disease would provide more transparent and reﬁned
discussions of risk and the opportunity for interventions to
improve this risk in this important, often disadvantaged,
population.Funding Source
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